LEO LUTWAK, M.D., Ph.D.; FREDERICK R. SINGER, M.D.; MARSHALL R. URIST, M.D.
Bone morphogenesis is a function of biochemical components of the organic matrix of bone, which consists of a noncollagenous protein resistant to solution, a solid support fibrous protein (collagen), and a neutral proteinase that degrades the noncollagenous protein. The proteinase functions in association with inhibitors that retard destruction of the protein and account for survival of morphogenetic activity in bone matrix. Calcitonin mediates another control mechanism for bone formation; it produces a decrease in osteoclasts, a delayed increase in osteoblasts, and significantly lowers plasma calcium and hydroxyproline concentrations in patients with increased bone turnover. Although calcitonin administration does not have a significant hypocalcemic effect in normal persons, the urinary excretion of dializable and nondializable peptides containing hydroxyproline is decreased. Chronic dietary insufficiency of calcium or excess of phosphate, or both, may lead to secondary nutritional hyperparathyroidism in animals and man, manifested primarily by increased resorption of trabecular bone. Osteoporosis of the jaw, leading to periodontal disease, is suggested as the precursor of the systemic osteoporosis seen in older patients.
LUTWAK L, SINGER FR, URIST MR. Current Concepts of Bone Metabolism. Ann Intern Med. 1974;80:630–644. doi: 10.7326/0003-4819-80-5-630
Download citation file:
Published: Ann Intern Med. 1974;80(5):630-644.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use